1. Market Research
  2. > Healthcare Market Trends
  3. > Patient Engagement Solutions Market by Component, Delivery mode, End User, Applications, Therapeutic Area - Global Forecast to 2020

Factors such as government regulations and initiatives, growing popularity of patient engagement solutions among the aging population, significant investments by stakeholders, and rising number of collaborations and partnerships between vendors and end users are some of the factors driving the growth of the patient engagement solutions market. Patient engagement solutions are gaining popularity across the globe; the use of health information technologies and online resources in healthcare boosts care quality by improving care access, efficiency, chronic disease management, and patient & family involvement. Patient engagement solutions offer various features that enhance patient-provider communication and involve patients in their own care. The benefits of patient engagement solutions have fueled their adoption globally. However, reluctance among providers towards the adoption of patient engagement solutions, requirement of infrastructural investments, and lack of interoperability are some of the factors expected to restrain the growth of this market. On the other hand, emerging economies in the Asian region, growing medical tourism, and growing use of cloud-based models offer growth opportunities for players in the market.

The software component segment is estimated to account for the largest share of the global patient engagement solutions market in 2015. Software is a non-tangible component used as an application to run a system or to perform primary tasks, which include maintaining patient records, analyzing databases, and performing administrative tasks in any healthcare organization or hospital.

Geographically, North America is expected to account for the largest share of the global patient engagement solutions market in 2015, followed by Europe, Asia, and the Rest of the World (RoW). The large share of North American is attributed to the federal mandates in the U.S., rising number of ACOs as end users for patient engagement solutions, rising aging population in the U.S, Canada’s efforts to enhance healthcare delivery, and digital health measures in Canada.

Major players in the market are focusing on various strategies, such as product deployments; agreements, alliances, collaborations, and partnerships; new product launches (including product enhancements); acquisitions; expansions; and other strategies (divestment, funding, and product integration), to establish a strong foothold in the global patient engagement solutions market.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the solutions offered by top players in the patient engagement solutions market. The report analyzes the patient engagement solutions market, by component, delivery mode, end user, application, and therapeutic area
- Product Development/Innovation: Detailed insights on research and development activities and new product launches in the patient engagement solutions market
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the patient engagement solutions market across regions
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the patient engagement solutions market
- Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the patient engagement solutions market

Table Of Contents

Patient Engagement Solutions Market by Component, Delivery mode, End User, Applications, Therapeutic Area - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH METHODOLOGY STEPS 24
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 25
2.2.1 SECONDARY RESEARCH 25
2.3 KEY DATA FROM SECONDARY SOURCES 25
2.3.1 PRIMARY RESEARCH 26
2.3.2 KEY INDUSTRY INSIGHTS 27
2.4 KEY DATA FROM PRIMARY SOURCES 28
2.5 KEY INSIGHTS FROM PRIMARY SOURCES 29
2.6 MARKET SIZE ESTIMATION METHODOLOGY 29
2.7 MARKET FORECAST METHODOLOGY 32
2.8 MARKET DATA VALIDATION AND TRIANGULATION 33
2.9 ASSUMPTIONS 33
3 EXECUTIVE SUMMARY 34
3.1 INTRODUCTION 34
3.2 CURRENT SCENARIO 34
3.3 FUTURE OUTLOOK 37
3.4 CONCLUSION 39
4 PREMIUM INSIGHTS 40
4.1 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET 40
4.2 GEOGRAPHIC ANALYSIS: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 41
4.3 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT (2015 VS. 2020) 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45
5.2 MARKET SEGMENTATION 45
5.3 MARKET DYNAMICS 46
5.3.1 DRIVERS 47
5.3.1.1 Government regulations and initiatives 47
5.3.1.2 Growing popularity of patient engagement solutions among the aging population 48
5.3.1.3 Significant investments by stakeholders 49
5.3.1.4 Rising number of collaborations and partnerships between vendors and end users 50
5.3.1.5 Increasing utilization of mobile health (mhealth) 51
5.3.2 RESTRAINTS 52
5.3.2.1 Reluctance among providers towards the adoption of patient engagement solutions 52
5.3.2.2 Requirement of infrastructural investments 52
5.3.2.3 Protection of patient information 52
5.3.2.4 Lack of interoperability 53
5.3.3 OPPORTUNITIES 54
5.3.3.1 Emerging economies in the Asian region 54
5.3.3.2 Growing medical tourism 54
5.3.3.3 Wearable health technology 54
5.3.3.4 Cloud-based models 55
5.3.4 CHALLENGES 56
5.3.4.1 High cost of deployment 56
5.3.4.2 Lack of health literacy 56
5.3.4.3 Dearth of skilled IT professionals in the healthcare industry 56
6 ADOPTION ASSESSMENT OF PATIENT ENGAGEMENT SOLUTIONS MARKET IN THE U.S. 58
6.1 INTRODUCTION 59
6.1.1 U.S.: PATIENT ENGAGEMENT SOLUTIONS ADOPTION ASSESSMENT, BY VENDOR 59
6.1.1.1 Medical Information Technology, Inc. 60
6.1.1.2 eClinicalWorks 60
6.1.1.3 athenahealth, Inc. 60
6.1.1.4 Allscripts Healthcare Solutions, Inc. 61
6.1.2 U.S.: PATIENT ENGAGEMENT SOLUTIONS ADOPTION ASSESSMENT, BY SOLUTION 61
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 63
7.1 INTRODUCTION 64
7.2 SOFTWARE 65
7.2.1 STANDALONE SOFTWARE 66
7.2.2 INTEGRATED SOFTWARE 67
7.3 SERVICES 68
7.4 HARDWARE 69
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE 70
8.1 INTRODUCTION 71
8.2 WEB-BASED 72
8.3 ON-PREMISE 73
8.4 CLOUD-BASED 74
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 75
9.1 INTRODUCTION 76
9.2 PROVIDERS 77
9.3 PAYERS 78
9.4 INDIVIDUAL USERS 79
9.5 OTHERS 80
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 82
10.1 INTRODUCTION 83
10.2 HEALTH MANAGEMENT 84
10.3 SOCIAL AND BEHAVIORAL MANAGEMENT 85
10.4 HOME HEALTH MANAGEMENT 86
10.5 FINANCIAL HEALTH MANAGEMENT 87
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 88
11.1 INTRODUCTION 89
11.2 CHRONIC DISEASES 90
11.2.1 DIABETES 91
11.2.2 CARDIOVASCULAR DISEASE 92
11.2.3 OBESITY 93
11.2.4 OTHER CHRONIC DISEASES 94
11.3 WOMEN'S HEALTH 95
11.4 FITNESS 96
11.5 OTHER THERAPEUTIC AREAS 96
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION 98
12.1 INTRODUCTION 99
12.2 NORTH AMERICA 101
12.2.1 U.S. 105
12.2.1.1 Legislations and initiatives to promote ‘patient-centeredness' in healthcare 105
12.2.1.2 Increasing number of accountable care organizations 106
12.2.1.3 Need to curb healthcare costs 107
12.2.1.4 Focus on shared decision-making 107
12.2.1.5 Hospital Readmissions Reduction Program (HRRP) 107
12.2.1.6 Pharmaceuticals industry propelling the patient engagement solutions market in U.S. 108
12.2.1.7 Increase in insurance coverage 108
12.2.1.8 Increasing investments in patient engagement 109
12.2.1.9 Impetus on fulfilling the requirements of ‘meaningful use' through patient engagement 109
12.2.1.10 Thrust given to API in stage 3 Meaningful Use Rules 110
12.2.2 CANADA 113
12.2.2.1 Digital health measures 113
12.2.2.2 Prevalence of chronic diseases 114
12.2.2.3 Patient engagement, a prerequisite for accreditation 114
12.3 EUROPE 117
12.3.1 RISING HEALTHCARE COSTS AND AGING POPULATION 117
12.3.2 GROWTH OF THE HCIT MARKET AND CONSOLIDATION OF HEALTHCARE PROVIDERS IN EUROPE 117
12.3.3 GROWING FOCUS ON EHEALTH 118
12.3.4 GERMANY 124
12.3.4.1 Rising demand for advanced healthcare solutions and efficient healthcare delivery in Germany 124
12.3.5 U.K. 127
12.3.5.1 Role of the NHS 127
12.3.6 FRANCE 130
12.3.6.1 Implementation of the Dossier Medical Personnel (DMP) in France 130
12.3.7 REST OF EUROPE (ROE) 133
12.4 ASIA 136
12.4.1 GROWTH IN MEDICAL TOURISM 136
12.4.2 NEED TO CONTROL RISING HEALTHCARE EXPENDITURE IN INDIA 137
12.4.3 JAPAN'S ICT POLICIES 137
12.4.4 ‘ONE SINGAPOREAN, ONE HEALTH RECORD' PROGRAM 137
12.4.5 GROWTH OF CHINA'S DIGITAL HEALTHCARE 138
12.4.6 “DIGITAL INDIA” CAMPAIGN AND DIGITAL HEALTHCARE SCENARIO IN INDIA 138
12.5 REST OF THE WORLD 142
12.5.1 PREVALENCE OF CHRONIC DISEASES 142
12.5.2 INCREASED HEALTHCARE SPENDING IN THE MIDDLE EAST 142
12.5.3 GROWTH OF THE HCIT MARKET IN LATIN AMERICA 143
12.5.4 PRODUCT DEPLOYMENTS AND HCIT PROGRAMS IN AUSTRALIA 143
13 COMPETITIVE LANDSCAPE 147
13.1 OVERVIEW 147
13.2 COMPETITIVE SITUATION AND TRENDS 148
13.2.1 PRODUCT DEPLOYMENTS 148
13.2.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 150
13.2.3 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 151
13.2.4 EXPANSIONS 152
13.2.5 ACQUISITIONS 153
13.2.6 OTHER STRATEGIES 154
14 COMPANY PROFILES 155
14.1 INTRODUCTION 155
14.2 MCKESSON CORPORATION 156
14.2.1 BUSINESS OVERVIEW 156
14.2.2 PRODUCTS OFFERED 157
14.2.3 RECENT DEVELOPMENTS 157
14.2.4 MNM VIEW 158
14.3 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 160
14.3.1 BUSINESS OVERVIEW 160
14.3.2 PRODUCTS and SERVICES OFFERED 161
14.3.3 RECENT DEVELOPMENTS 161
14.3.4 MNM VIEW 164
14.4 PHYTEL, INC. (ACQUIRED BY IBM CORPORATION) 165
14.4.1 BUSINESS OVERVIEW 165
14.4.2 PRODUCTS OFFERED 166
14.4.3 RECENT DEVELOPMENTS 166
14.4.4 MNM VIEW 168
14.5 ATHENAHEALTH, INC. 169
14.5.1 BUSINESS OVERVIEW 169
14.5.2 PRODUCTS and SERVICES OFFERED 170
14.5.3 RECENT DEVELOPMENTS 170
14.5.4 MNM VIEW 174
14.6 CERNER CORPORATION 175
14.6.1 BUSINESS OVERVIEW 175
14.6.2 PRODUCTS OFFERED 176
14.6.3 RECENT DEVELOPMENTS 176
14.6.4 MNM VIEW 179
14.7 ORION HEALTH LTD. 180
14.7.1 BUSINESS OVERVIEW 180
14.7.2 PRODUCTS OFFERED 180
14.7.3 RECENT DEVELOPMENTS 181
14.8 GETWELLNETWORK, INC. 183
14.8.1 BUSINESS OVERVIEW 183
14.8.2 PRODUCTS OFFERED 183
14.8.3 RECENT DEVELOPMENTS 183
14.9 LINCOR SOLUTIONS LTD. 186
14.9.1 BUSINESS OVERVIEW 186
14.9.2 PRODUCTS OFFERED 186
14.9.3 RECENT DEVELOPMENTS 186
14.10 YOURCAREUNIVERSE, INC. 188
14.10.1 BUSINESS OVERVIEW 188
14.10.2 PRODUCTS OFFERED 188
14.10.3 RECENT DEVELOPMENTS 189
14.11 WELVU, INC. 191
14.11.1 BUSINESS OVERVIEW 191
14.11.2 PRODUCTS OFFERED 191
14.11.3 RECENT DEVELOPMENTS 191
14.12 GET REAL HEALTH 193
14.12.1 BUSINESS OVERVIEW 193
14.12.2 PRODUCTS AND SERVICES OFFERED 193
14.12.3 RECENT DEVELOPMENTS 193
14.13 ONEVIEW HEALTHCARE 196
14.13.1 BUSINESS OVERVIEW 196
14.13.2 PRODUCTS OFFERED 196
14.13.3 RECENT DEVELOPMENTS 196
14.14 PATIENTPOINT 198
14.14.1 BUSINESS OVERVIEW 198
14.14.3 RECENT DEVELOPMENTS 198
14.15 MEDECISION INC. 201
14.15.1 BUSINESS OVERVIEW 201
14.15.2 PRODUCTS OFFERED 201
14.15.3 RECENT DEVELOPMENTS 201
14.16 EMMI SOLUTIONS, LLC 203
14.16.1 BUSINESS OVERVIEW 203
14.16.2 PRODUCTS and SERVICES OFFERED 203
14.16.3 RECENT DEVELOPMENTS 203
15 APPENDIX 206
15.1 DISCUSSION GUIDE 206
15.2 OTHER DEVELOPMENTS, BY COMPANY (2013-2016) 211
15.2.1 MCKESSON CORPORATION 211
15.2.2 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 211
15.2.3 PHYTEL (ACQUIRED BY IBM) 214
15.2.4 ATHENAHEALTH, INC. 216
15.2.5 ORION HEALTH LTD. 219
15.2.6 CERNER CORPORATION 220
15.2.7 GETWELLNETWORK, INC. 222
15.2.8 LINCOR SOLUTIONS LTD. 224
15.2.9 YOURCAREUNIVERSE, INC. 225
15.2.10 GET REAL HEALTH 225
15.2.11 ONEVIEW HEALTHCARE 226
15.2.12 PATIENTPOINT 227
15.2.13 MEDECISION INC. 228
15.2.14 EMMI SOLUTIONS, LLC 228
15.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 230
15.4 AVAILABLE CUSTOMIZATIONS 230
15.5 RELATED REPORTS 231


LIST OF TABLES

TABLE 1 FEDERAL MANDATES ARE PROPELLING THE GROWTH OF GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET 48
TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM
2013-2015 50
TABLE 3 RELUCTANCE AMONG PROVIDERS FOR THE ADOPTION OF PATIENT ENGAGEMENT SOLUTIONS ACTS AS A KEY RESTRAINT 53
TABLE 4 CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS OFFER A HUGE POTENTIAL FOR THE MARKET GROWTH 55
TABLE 5 LACK OF HEALTH LITERACY IS A MAJOR CHALLENGE FOR THE PATIENT ENGAGEMENT SOLUTIONS MARKET 57
TABLE 6 TOP THREE PATIENT ENGAGEMENT SOLUTIONS DEPLOYED (JAN 2013-JAN 2016) 62
TABLE 7 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION) 64
TABLE 8 PATIENT ENGAGEMENT SOFTWARE MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 65
TABLE 9 PATIENT ENGAGEMENT SOFTWARE MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 66
TABLE 10 PATIENT ENGAGEMENT STANDALONE SOFTWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 66
TABLE 11 PATIENT ENGAGEMENT INTEGRATED SOFTWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 67
TABLE 12 PATIENT ENGAGEMENT SERVICES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 68
TABLE 13 PATIENT ENGAGEMENT HARDWARE MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 69
TABLE 14 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 71
TABLE 15 WEB-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 72
TABLE 16 ON-PREMISE PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 73
TABLE 17 CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 74
TABLE 18 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 77
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HEALTHCARE PROVIDERS, BY REGION, 2013-2020 (USD MILLION) 78
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HEALTHCARE PAYERS,
BY REGION, 2013-2020 (USD MILLION) 79
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR INDIVIDUAL USERS,
BY REGION, 2013-2020 (USD MILLION) 80
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHERS, BY REGION, 2013-2020 (USD MILLION) 81
TABLE 23 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 83
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HEALTH MANAGEMENT,
BY REGION, 2013-2020 (USD MILLION) 84
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR SOCIAL AND BEHAVIORAL MANAGEMENT, BY REGION, 2013-2020 (USD MILLION) 85
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HOME HEALTH MANAGEMENT, BY REGION, 2013-2020 (USD MILLION) 86
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2013-2020 (USD MILLION) 87
TABLE 28 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 90
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CHRONIC DISEASES,
BY REGION, 2013-2020 (USD MILLION) 90
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CHRONIC DISEASES,
BY TYPE, 2013-2020 (USD MILLION) 91
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR DIABETES,
BY REGION, 2013-2020 (USD MILLION) 92
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CARDIOVASCULAR DISEASE, BY REGION, 2013-2020 (USD MILLION) 93
TABLE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OBESITY,
BY REGION, 2013-2020 (USD MILLION) 94
TABLE 34 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHER CHRONIC DISEASES, BY REGION, 2013-2020 (USD MILLION) 94
TABLE 35 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR WOMEN'S HEALTH,
BY REGION, 2013-2020 (USD MILLION) 95
TABLE 36 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR FITNESS,
BY REGION, 2013-2020 (USD MILLION) 96
TABLE 37 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHER THERAPEUTIC AREAS, BY REGION, 2013-2020 (USD MILLION) 97
TABLE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 99
TABLE 39 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 101
TABLE 40 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE,
BY COMPONENT, 2013-2020 (USD MILLION) 103
TABLE 41 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE,
BY DELIVERY MODE, 2013-2020 (USD MILLION) 103
TABLE 42 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE,
BY END USER, 2013-2020 (USD MILLION) 104
TABLE 43 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 104
TABLE 44 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 105
TABLE 45 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT,
2013-2020 (USD MILLION) 111
TABLE 46 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 111
TABLE 47 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 112
TABLE 48 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 112
TABLE 49 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 113
TABLE 50 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION) 114
TABLE 51 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 115
TABLE 52 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 115
TABLE 53 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 116
TABLE 54 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 116
TABLE 55 INDICATIVE LIST OF EHEALTH PROJECTS UNDERTAKEN BY THE EUROPEAN UNION 118
TABLE 56 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 120
TABLE 57 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION) 122
TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 122
TABLE 59 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 123
TABLE 60 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 123
TABLE 61 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 124
TABLE 62 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION) 125
TABLE 63 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 125
TABLE 64 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 126
TABLE 65 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 126
TABLE 66 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 127
TABLE 67 U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT,
2013-2020 (USD MILLION) 128
TABLE 68 U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 128
TABLE 69 U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 129
TABLE 70 U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 129
TABLE 71 U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 130
TABLE 72 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION) 131
TABLE 73 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 131
TABLE 74 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 132
TABLE 75 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 132
TABLE 76 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 133
TABLE 77 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT,
2013-2020 (USD MILLION) 134
TABLE 78 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 134
TABLE 79 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 135
TABLE 80 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 135
TABLE 81 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 136
TABLE 82 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT,
2013-2020 (USD MILLION) 140
TABLE 83 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 140
TABLE 84 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 141
TABLE 85 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 141
TABLE 86 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 142
TABLE 87 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT,
2013-2020 (USD MILLION) 144
TABLE 88 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 145
TABLE 89 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 145
TABLE 90 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION
2013-2020 (USD MILLION) 146
TABLE 91 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION) 146
TABLE 92 PRODUCT DEPLOYMENTS, 2013-2016 149
TABLE 93 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2013-2016 150
TABLE 94 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2013-2016 151
TABLE 97 OTHER DEVELOPMENTS, 2013-2016 154


LIST OF FIGURES

FIGURE 1 GLOBAL PATIENT ENGAGEMENT MARKET: RESEARCH METHODOLOGY STEPS 24
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 27
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 30
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 31
FIGURE 6 RESEARCH DESIGN 32
FIGURE 7 DATA TRIANGULATION METHODOLOGY 33
FIGURE 8 NORTH AMERICA DOMINATES THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015 36
FIGURE 9 PROVIDERS SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020 38
FIGURE 10 EUROPE TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 38
FIGURE 11 PATIENT ENGAGEMENT SOLUTIONS TO REGISTER DOUBLE DIGIT GROWTH IN THE FORECAST PERIOD 40
FIGURE 12 NORTH AMERICA DOMINATES THE PATIENT ENGAGEMENT SOLUTIONS MARKET
IN 2015 41
FIGURE 13 EUROPEAN REGION TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 42
FIGURE 14 SOFTWARE SEGMENT COMMANDS THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015 43
FIGURE 15 GLOBAL PATIENT ENGAGEMENT SOLUTIONA MARKET 45
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, and CHALLENGES 46
FIGURE 17 LEADING VENDORS PROVIDING PATIENT ENGAGEMENT SOLUTIONS TO HEALTHCARE PROVIDERS (JAN 2013-JAN 2016) 59
FIGURE 18 PATIENT ENGAGEMENT SOLUTIONS ADOPTED IN U.S. (JAN 2013 TO JAN 2016) 61
FIGURE 20 PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE 65
FIGURE 22 HEALTHCARE PROVIDERS TO ACCOUNT FOR THE LARGEST SHARE OF PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015 76
FIGURE 25 EUROPE TO GROW AT THE HIGHEST CAGR IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015 100
FIGURE 26 U.S. COMMANDS THE LARGEST SHARE IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN NORTH AMERICA 102
FIGURE 27 GERMANY COMMANDS THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN EUROPE 121
FIGURE 28 ASIA COMMANDS FOR THE THIRD LARGEST MARKET SHARE OF THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET 139
FIGURE 29 PROVIDERS IN END-USERS SEGMENT DOMINATES ROW PATIENT ENGAGEMENT SOLUTIONS MARKET 144
FIGURE 30 TOP 5 STRATEGIES ADOPTED BY PLAYERS DURING 2013-2016 147
FIGURE 31 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013-2016) 148
FIGURE 32 GEOGRAPHIC REVENUE MIX OF MARKET PLAYERS 155
FIGURE 33 MCKESSON CORPORATION: COMPANY SNAPSHOT 156
FIGURE 34 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT 160
FIGURE 35 IBM CORPORATION: COMPANY SNAPSHOT 165
FIGURE 36 ATHENAHEALTH, INC.: COMPANY SNAPSHOT 169
FIGURE 37 CERNER CORPORATION: COMPANY SNAPSHOT 175
FIGURE 38 ORION HEALTH LTD.: COMPANY SNAPSHOT 180

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.